Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)

NCT00644371 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin Lymphoma

Interventions

DRUG: Ibritumomab Tiuxetan (Zevalin)

Sponsor

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea